The FDA has granted priority review to Intellia’s biologics license application for lonvo-z and plans to issue a decision by March 10, 2027.

The accelerated approval was based on results from the Phase I/II SOHO-01 trial showing a 75 percent response rate to ...

The Dow Jones Industrial Average rose 1 percent month over month, the Nasdaq rose 4 percent, and the Nasdaq Biotech Index rose 10 percent.

The partners will create a secure, Rush-hosted clinical analytics platform to enable Rush researchers to analyze deidentified, longitudinal, and multimodal clinical data.

The bank gave CareDx a price target of $65 per share and BillionToOne of $120 per share,  noting their strong positions in non-oncology markets and recent moves into cancer testing.

The effort, called SepTech, will begin on Sept. 1 and run through August 2029, and it picks up from an earlier project called ...

NEW YORK – An advertising watchdog has recommended that controversial DNA testing and embryo screening company Nucleus Genomics stop use of what it characterizes as inaccurate advertising claims.

Google DeepMind has launched AlphaGenome Atlas ...

BGI Genomics has launched the Family Heritage genomic assay, a whole-genome test that combines short- and long-read sequencing for family members.

NEW YORK – Tempus AI said on Friday that it is building a database containing 100,000 whole genomes linked to longitudinal clinical information over the next several years to help advance artificial ...

Moonwalk Biosciences said it will use the funds to advance its lead candidate for obesity, MW101, into clinical testing by late 2027.

NEW YORK – Clinical labs are raising concerns over a proposed rule by the US Centers for Medicare and Medicaid Services (CMS) that would move reimbursement for algorithm-only lab testing off the ...